Castilla Lab

The Castilla laboratory studies the mechanism of leukemia development using mouse models. To this end, researchers in the Castilla Lab have developed sophisticated mouse models for acute myeloid leukemia to study the mechanisms dictating leukemia development, including conditional knockins.  These are utilized with tissue specific and inducible Cre transgenic mice to better understand the function of driver-mutations in a cell type specific manner. Researchers also utilize and patient derived xenografts to study clonal complexity of patient AML blasts and therapeutic efficacy in vivo. 

  • Kuo et al. (2006) Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell 2006, 9(1):57-68.
  • Pullikan et al. (2012) Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling. Blood, 120(4):868-79.
  • Illendula et al. (2015) Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice.  Science, 347(6223):779-84.